Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 27-Feb-24 4:59 PM View:  | Vertex Pharmaceuticals Inc. (VRTX) | 26-Feb-24 | Sale (Planned) | 3,004 | $425.70 | $1,278,800.00 | (5%) 65.78K to 62.77K | |
| 27-Feb-24 4:59 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 23-Feb-24 | Payment of Exercise | 2,469 | $431.79 | $1,066,090.00 | (4%) 68.25K to 65.78K | |
| 23-Feb-24 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Feb-24 | Private Sale (Planned) | 3,191 | $421.77 | $1,345,870.00 | (4%) 71.44K to 68.25K | |
| 21-Feb-24 4:38 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Feb-24 | Payment of Exercise | 2,623 | $420.58 | $1,103,180.00 | (3%) 78.31K to 75.69K | |
| 21-Feb-24 4:38 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Feb-24 | Sale (Planned) | 4,254 | $420.79 | $1,790,040.00 | (6%) 75.69K to 71.44K | |
| 21-Feb-24 4:38 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Feb-24 | Payment of Exercise | 3,498 | $424.01 | $1,483,190.00 | (4%) 81.81K to 78.31K | |
| 13-Feb-24 5:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-Feb-24 | Sale (Planned) | 3,222 | $420.24 | $1,354,010.00 | (4%) 85.03K to 81.81K | |
| 13-Feb-24 5:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Feb-24 | Payment of Exercise | 2,022 | $422.74 | $854,780.00 | (2%) 87.06K to 85.03K | |
| 08-Feb-24 4:43 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Feb-24 | Grant | 7,114 | -- | -- | 9% 79.94K to 87.06K | |
| 08-Feb-24 4:43 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-24 | Grant | 13,680 | -- | -- | 21% 66.26K to 79.94K | |
| 17-Nov-23 4:16 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Nov-23 | Private Sale (Planned) | 35 | $369.92 | $12,947.20 | (< 1%) 66.3K to 66.26K | |
| 14-Aug-23 4:05 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Aug-23 | Private Sale (Planned) | 10,031 | $350.00 | $3,510,850.00 | (13%) 76.29K to 66.26K | |
| 28-Feb-23 5:02 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-23 | Payment of Exercise | 2,468 | $289.12 | $713,548.00 | (3%) 78.73K to 76.26K | |
| 22-Feb-23 4:43 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-23 | Payment of Exercise | 3,498 | $292.85 | $1,024,390.00 | (4%) 82.23K to 78.73K | |
| 14-Feb-23 5:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-23 | Payment of Exercise | 4,657 | $298.26 | $1,389,000.00 | (5%) 86.88K to 82.23K | |
| 14-Feb-23 5:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-23 | Payment of Exercise | 2,611 | $294.33 | $768,496.00 | (3%) 89.5K to 86.88K | |
| 03-Feb-23 4:56 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-23 | Grant | 26,400 | -- | -- | 36% 74.15K to 100.55K | |
| 03-Feb-23 4:56 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-May-22 | Gift | 1,672 | -- | -- | (2%) 75.82K to 74.15K | |
| 11-Mar-22 9:07 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 11-Mar-22 | Grant | 6,000 | -- | -- | 60% 10.0K to 16.0K | |
| 28-Feb-22 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-22 | Payment of Exercise | 7,368 | $227.86 | $1,678,870.00 | (10%) 72.03K to 64.67K | |
| 22-Feb-22 5:01 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-22 | Payment of Exercise | 3,497 | $232.51 | $813,087.00 | (5%) 75.53K to 72.03K | |
| 14-Feb-22 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-22 | Payment of Exercise | 2,491 | $237.74 | $592,210.00 | (3%) 78.02K to 75.53K | |
| 03-Feb-22 4:24 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-22 | Grant | 29,638 | -- | -- | 61% 48.38K to 78.02K | |
| 16-Nov-21 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Nov-21 | Private Sale (Planned) | 51 | $187.19 | $9,546.78 | (< 1%) 48.43K to 48.38K | |
| 19-May-21 4:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-May-21 | Private Sale (Planned) | 45 | $216.35 | $9,735.87 | (< 1%) 48.43K to 48.38K | |
| 29-Apr-21 4:03 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 27-Apr-21 | Option Exercise | 3,884 | $86.52 | $336,044.00 | 8% 48.38K to 52.27K | |
| 29-Apr-21 4:03 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 27-Apr-21 | Planned Option Sale | 3,884 | $216.06 | $839,193.00 | (7%) 52.27K to 48.38K | |
| 15-Mar-21 7:39 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-21 | Grant | 5,000 | -- | -- | 100% 5.0K to 10.0K | |
| 26-Feb-21 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Feb-21 | Sale (Planned) | 3,586 | $213.41 | $765,307.00 | (7%) 51.97K to 48.38K | |
| 26-Feb-21 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-21 | Payment of Exercise | 2,946 | $217.57 | $640,961.00 | (5%) 54.91K to 51.97K | |
| 19-Feb-21 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 18-Feb-21 | Sale (Planned) | 9,264 | $211.83 | $1,962,370.00 | (14%) 64.18K to 54.91K | |
| 19-Feb-21 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-21 | Payment of Exercise | 7,613 | $211.75 | $1,612,050.00 | (11%) 71.79K to 64.18K | |
| 16-Feb-21 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-Feb-21 | Private Sale (Planned) | 4,460 | $210.55 | $939,068.00 | (6%) 76.25K to 71.79K | |
| 12-Feb-21 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-21 | Payment of Exercise | 2,421 | $214.16 | $518,481.00 | (3%) 78.67K to 76.25K | |
| 05-Feb-21 4:53 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-21 | Grant | 32,077 | -- | -- | 69% 46.6K to 78.67K | |
| 05-Feb-21 4:53 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-Dec-20 | Gift | 3,391 | -- | -- | (7%) 49.99K to 46.6K | |
| 18-Nov-20 4:16 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Nov-20 | Private Sale (Planned) | 42 | $223.53 | $9,388.24 | (< 1%) 50.03K to 49.99K | |
| 05-Aug-20 4:51 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Aug-20 | Option Exercise | 1,941 | $86.52 | $167,935.00 | 4% 49.99K to 51.93K | |
| 05-Aug-20 4:51 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Aug-20 | Planned Option Sale | 1,941 | $278.28 | $540,137.00 | (4%) 51.93K to 49.99K | |
| 19-May-20 4:29 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-May-20 | Private Sale (Planned) | 58 | $284.41 | $16,495.70 | (< 1%) 50.05K to 49.99K | |
| 13-May-20 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-May-20 | Option Exercise | 10,665 | $131.89 | $1,406,610.00 | 21% 49.99K to 60.65K | |
| 13-May-20 4:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-May-20 | Planned Option Sale | 10,665 | $282.61 | $3,014,010.00 | (18%) 60.65K to 49.99K | |
| 08-May-20 4:23 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-May-20 | Option Exercise | 669 | $131.89 | $88,234.40 | 1% 49.99K to 50.66K | |
| 08-May-20 4:23 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-May-20 | Planned Option Sale | 669 | $275.28 | $184,162.00 | (1%) 50.66K to 49.99K | |
| 06-May-20 4:43 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-May-20 | Option Exercise | 13,356 | $131.89 | $1,761,520.00 | 27% 49.99K to 63.34K | |
| 06-May-20 4:43 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-May-20 | Planned Option Sale | 13,356 | $270.01 | $3,606,230.00 | (21%) 63.34K to 49.99K | |
| 06-May-20 4:43 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-May-20 | Option Exercise | 43,752 | $112.98 | $4,942,970.00 | 88% 49.99K to 93.74K | |
| 06-May-20 4:43 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 04-May-20 | Planned Option Sale | 43,752 | $262.28 | $11,475,200.00 | (47%) 93.74K to 49.99K | |
| 13-Mar-20 5:38 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-20 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 26-Feb-20 4:36 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 25-Feb-20 | Sale (Planned) | 3,376 | $233.53 | $788,402.00 | (6%) 53.36K to 49.99K |